Back to search
Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatocellular Carcinoma With Major Portal Vein Thrombosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatocellular Carcinoma With Major Portal Vein Thrombosis trials you may qualify forHepatic artery infusion chemotherapy (HAIC) and anti-programmed cell death protein-1ligand (PD-L1) immunotherapy have shown promising outcomes in patients with…
According to the Barcelona clinic liver cancer (BCLC) staging treatment guideline, sorafenib is recommended for Hepatocellular Carcinoma (HCC) with Portal Vein…
This is a randomized, double-blinded, controlled, phase II study. The purpose is to evaluate efficacy and safety of the combination therapy of HAIC (Hepatic art…
Recently, several studies reported promising outcomes of patients after external beam radiotherapy (EBRT) for hepatocellular carcinoma (HCC) with portal vein tu…
The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin plus fluorouracil/leucovorin co…